Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study
: By constructing clusters based on the aggregate of genomic alterations in patients with actionable mutations, it is possible to predict associations with distinct demographic and clinical characteristics. Future research should apply this analytical approach to larger cohorts to further characterize these subgroups and investigate potential correlations with therapeutic efficacy.
Authors
- Leonard Saiegh (ORCID: https://orcid.org/0000-0001-5771-6569)
- Salam Mazareb
- Edmond Sabo
- Abed Agbarya (ORCID: https://orcid.org/0000-0002-3330-2959)
- Kamel Mhameed
- Walid Shalata (ORCID: https://orcid.org/0000-0002-7570-4550)
- Dan Levy Faber (ORCID: https://orcid.org/0000-0003-4558-4858)
- Haitam Nasrallah
- Mohammad Sheikh-Ahmad
- Yuval Shaham
Institutions
- Ben-Gurion University of the Negev (IL)
- Technion – Israel Institute of Technology (IL)
- Soroka Medical Center (IL)
- Rambam Health Care Campus (IL)
- Bnai Zion Medical Center (IL)
- Carmel Medical Center (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
Publication Details
- Journal
- Diagnostics
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/diagnostics16071106
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00